slows worsening of microalbuminuria and attenuates progression of diabetic nephropathy, even in advanced stages. In addition to blood pressure, proteinuria is a treatment target and should be ...

Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...

1 All patients received standard treatment for diabetic nephropathy (including angiotensin-converting-enzyme inhibitors or angiotensin-receptor blockers) and were randomly allocated to receive 25 ...

Egypt: A recent randomized controlled trial has demonstrated that sitagliptin, a DPP-4 inhibitor, significantly improves ...

As part of its ongoing RAK Diabetes Challenge community initiative, RAK Hospital held an insightful Diabeat Webinar on the ...

Diabetes and obesity are intertwined health conditions with serious consequences if left unmanaged. Obesity increases the ...

As part of its ongoing RAK diabetes Challenge community initiative, RAK Hospital held an insightful Diabeat Webinar on the LINK between diabetes and kidney disease, shedding light on the prevention ...

A year-long integrated, intensive action plan is being chalked out to augment all diabetes control programmes in the State. The programme, which will be kicked off on November 14, World Diabetes Day, ...

IgA nephropathy (IgAN) is an autoimmune kidney ... and after felzartamab treatment. Samples were assessed for immune cells, antibodies, and immunoglobulins including Gd-IgA1.